Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
807.45
792.41
773.00
705.30
727.45
741.17
719.72
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
807.45
792.41
773.00
705.30
727.45
741.17
719.72
Raw Material Cost
105.85
82.58
70.10
68.28
69.43
72.16
66.47
Purchase of Finished goods
117.24
146.09
104.26
95.98
133.22
118.35
125.57
(Increase) / Decrease In Stocks
0.21
-26.26
10.28
5.99
-25.77
-4.24
-11.45
Employee Cost
138.08
137.45
144.43
121.45
125.39
125.63
132.62
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
164.46
164.34
167.22
161.21
174.87
164.76
156.52
Total Expenditure (Excl Depreciation)
525.84
504.20
496.29
452.91
477.14
476.66
469.73
Operating Profit (PBDIT) excl Other Income
281.61
288.21
276.71
252.39
250.31
264.51
249.99
Other Income
0.02
2.81
2.69
7.95
4.22
4.55
1.64
Operating Profit (PBDIT)
281.63
291.02
279.40
260.34
254.53
269.06
251.63
Interest
48.82
49.55
48.68
54.28
57.17
59.47
60.37
Exceptional Items
-17.24
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
215.57
241.47
230.72
206.06
197.36
209.59
191.26
Depreciation
70.34
69.08
70.51
77.25
81.00
80.48
75.74
Profit Before Tax
145.35
172.67
161.10
128.87
116.36
129.11
115.52
Tax
36.52
38.20
36.00
26.52
29.30
32.76
25.97
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
108.71
134.19
124.21
102.29
87.06
96.35
89.55
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
108.71
134.19
124.21
102.29
87.06
96.35
89.55
Share in Profit of Associates
0.12
0.28
0.89
0.06
0.00
0.00
0.00
Minority Interest
9.11
14.28
7.11
8.51
3.30
4.76
6.24
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
99.72
120.19
117.99
93.84
83.76
91.59
83.31
Equity Capital
13.61
13.62
13.62
13.62
13.61
13.61
13.61
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
3,077.54
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
7.33
8.82
8.66
6.89
6.15
6.73
6.12
Diluted Earnings per share
7.31
8.81
8.64
6.89
6.15
6.72
6.1
Operating Profit Margin (Excl OI)
35.16%
36.48%
35.86%
35.92%
34.66%
35.8%
34.93%
Gross Profit Margin
26.92%
30.56%
29.9%
29.33%
27.33%
28.36%
26.73%
PAT Margin
13.59%
17.02%
16.21%
14.57%
12.06%
13.04%
12.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is 11.00% vs 49.59% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is 19.05% vs -18.47% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is 12.50% vs 42.62% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is -14.61% vs 215.51% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
Compare Quarterly Results Of ERIS Lifescience With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
807.45
2,139.87
-1,332.42
-62.27%
Other Operating Income
0.00
0.00
0.00
Total Operating income
807.45
2,139.87
-1,332.42
-62.27%
Raw Material Cost
105.85
505.48
-399.63
-79.06%
Purchase of Finished goods
117.24
376.84
-259.60
-68.89%
(Increase) / Decrease In Stocks
0.21
-96.01
96.22
100.22%
Employee Cost
138.08
599.85
-461.77
-76.98%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
164.46
557.98
-393.52
-70.53%
Total Expenditure (Excl Depreciation)
525.84
1,944.14
-1,418.30
-72.95%
Operating Profit (PBDIT) excl Other Income
281.61
195.73
85.88
43.88%
Other Income
0.02
43.24
-43.22
-99.95%
Operating Profit (PBDIT)
281.63
238.97
42.66
17.85%
Interest
48.82
89.24
-40.42
-45.29%
Exceptional Items
-17.24
-41.11
23.87
58.06%
Gross Profit (PBDT)
215.57
108.62
106.95
98.46%
Depreciation
70.34
212.74
-142.40
-66.94%
Profit Before Tax
145.35
-93.86
239.21
254.86%
Tax
36.52
42.33
-5.81
-13.73%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
108.71
-146.45
255.16
174.23%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
108.71
-146.45
255.16
174.23%
Share in Profit of Associates
0.12
10.26
-10.14
-98.83%
Minority Interest
9.11
0.00
9.11
Other related items
0.00
0.00
0.00
Consolidated Net Profit
99.72
-136.19
235.91
173.22%
Equity Capital
13.61
1,325.83
-1,312.22
-98.97%
Face Value
1.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
7.33
-1.03
8.36
811.65%
Diluted Earnings per share
7.31
-1.03
8.34
809.71%
Operating Profit Margin (Excl OI)
35.16%
9.15%
0.00
26.01%
Gross Profit Margin
26.92%
5.08%
0.00
21.84%
PAT Margin
13.59%
-6.36%
0.00
19.95%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 807.45 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is 1.90% vs 2.51% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 11.00% vs 49.59% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 99.72 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -17.03% vs 1.86% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 19.05% vs -18.47% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 281.61 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -2.29% vs 4.16% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 12.50% vs 42.62% in Dec 2024
Quarterly - Interest
Interest 48.82 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -1.47% vs 1.79% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -14.61% vs 215.51% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.16%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
